A Breakthrough in Dialysis Access ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Amplifi Vascular, Inc., has been granted Breakthrough Device Designation and Category B assignment from the Centers for Medicare & Medicaid Services (CMS) for the Amplifi Vein Dilation System. This significant...
Hence then, the article about amplifi vascular gains fda breakthrough device status cms category b was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Amplifi Vascular Gains FDA Breakthrough Device Status & CMS Category B )
Also on site :
- Pop Star Makes Streaming History with Record-Breaking Third Album Just One Day After Release
- UK and Japan poised to seal landmark £18 billion investment deal to create thousands of jobs
- Marler Clark Urges Parents to Stop Using Nara Organics Whole Milk Organic Powdered Infant Formula Amid Multistate Infant Botulism Outbreak -- Product Sold Nationwide at Target